Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

Phyllochinon

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

28 API Suppliers, 13 USDMF, 3 CEP/COS, 4 JDMF, 5 EU WC, 2 NDC API, 13 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

FINISHED DOSAGE FORMULATIONS

113 FDF Dossiers, 39 FDA Orange Book, 25 Europe, 4 Canada, 1 Australia, 25 South Africa, 19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 10MG/ML ***Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 1MG/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML, INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL, INJECTABLE;INJECTION - 1MG/0.5ML, INJECTABLE;INJECTION - 1MG/0.5ML, INJECTABLE;INJECTION - 10MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 16 SPI Pharma, 3 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 Kirsch Pharma, 3 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 BASF, 1 Corel Pharma Chem, 2 Finar, 8 Gangwal Chemicals, 2 Gloria Interchem, 3 Ingredion Pharma Solutions, 3 Kerry, 3 Lonza Capsugel, 8 Microlex e.U, 2 Nanjing Bold Chemical, 1 Neelkanth MineChem, 1 Nitika Pharmaceutical Specialities, 5 Pluviaendo, 1 Prachin Chemical, 1 Qualicaps, 15 Roquette, 9 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 3 Sigachi Industries, 1 Silverline Chemicals, 1 Valens Pharmachem, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

39 Fillers, Diluents & Binders, 28 Parenteral, 21 Solubilizers, 18 Direct Compression, 16 Chewable & Orodispersible Aids, 15 Taste Masking, 14 Topical, 12 Lubricants & Glidants, 11 Emulsifying Agents, 10 Disintegrants & Superdisintegrants, 9 Thickeners and Stabilizers, 9 Co-Processed Excipients, 8 Film Formers & Plasticizers, 8 Empty Capsules, 7 API Stability Enhancers, 7 Granulation, 7 Surfactant & Foaming Agents, 5 Coating Systems & Additives, 2 Controlled & Modified Release, 1 Rheology Modifiers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 26 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 Regulatory FDF Prices, 3 Annual Reports

MARKET PLACE

34 APIs, 8 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 2 JP, 3 Others

ANALYTICAL

1 Analytical Methods

1 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
31/03/2026	Chemicrea	Japan	Chemicrea Co., Ltd.	217MF11147	Japanese Pharmacopoeia Menatetrenone (for manufacturing...	2005-12-05	2006-12-18	Quattro Muromachi Building 9F, 4-1-6 Nihonbashi Muromachi, Chuo-ku, Tokyo
31/03/2026	NISSHIN PHARMA INC	Japan	Nissin Pharma Co., Ltd.	217MF11106	Phytonazion	2005-12-05	2009-05-13	1-25 Kanda Nishikicho, Chiyoda-ku, Tokyo

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Phyllochinon

Phyllochinon

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

28 API Suppliers

13 USDMF

3 CEP/COS

4 JDMF

5 EU WC

2 NDC API

13 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

FINISHED DOSAGE FORMULATIONS

113 FDF Dossiers

39 FDA Orange Book

25 Europe

4 Canada

1 Australia

25 South Africa

19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 10MG/ML ***Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 1MG/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML

INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL

INJECTABLE;INJECTION - 1MG/0.5ML

INJECTABLE;INJECTION - 1MG/0.5ML

INJECTABLE;INJECTION - 10MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Rochem International Inc

16 SPI Pharma

3 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 Kirsch Pharma

3 Dr. Paul Lohmann GmbH & Co. KGaA

4 ACG Worldwide

6 Actylis

1 Aeon Procare

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

8 BASF

1 Corel Pharma Chem

2 Finar

8 Gangwal Chemicals

2 Gloria Interchem

3 Ingredion Pharma Solutions

3 Kerry

3 Lonza Capsugel

8 Microlex e.U

2 Nanjing Bold Chemical

1 Neelkanth MineChem

1 Nitika Pharmaceutical Specialities

5 Pluviaendo

1 Prachin Chemical

1 Qualicaps

15 Roquette

9 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

3 Sigachi Industries

1 Silverline Chemicals

1 Valens Pharmachem

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

39 Fillers, Diluents & Binders

28 Parenteral

21 Solubilizers

18 Direct Compression

16 Chewable & Orodispersible Aids

15 Taste Masking

14 Topical

12 Lubricants & Glidants

TABLET;ORAL - 5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 10MG/ML *Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 1MG/0.5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons